Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Pfizer
(NY:
PFE
)
29.22
-0.05 (-0.17%)
Official Closing Price
Updated: 7:00 PM EDT, Oct 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Pfizer
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
3 High-Growth Dividend Stocks to Own for the Next 10 Years
August 08, 2024
Discover the best high-growth dividend stocks with strong fundamentals across integrated telecommunication, retail REITs, and pharmaceuticals.
Via
InvestorPlace
The 7 Best Stocks to Buy in August 2024
August 08, 2024
Investors on the hunt for bargains among the current market volatility should consider these seven best stocks to buy.
Via
InvestorPlace
The 3 Best Biotech Stocks to Buy in August 2024
August 08, 2024
These biotech stocks are leading the way with groundbreaking therapies and robust fundamentals offering superb upside ahead.
Via
InvestorPlace
Here's Why Eli Lilly Stock Dropped 12% Last Month
August 08, 2024
News from a competitor gave investors an unwelcome dose of reality.
Via
The Motley Fool
Warren Buffett's Approach To Investing In Election Years
August 07, 2024
Warren Buffett, known as the 'Oracle of Omaha', is a highly successful American investor who manages his portfolio consistently, regardless of elections or market conditions.
Via
Benzinga
Is Pfizer Winning Its $43 Billion Bet?
August 02, 2024
Pfizer's efforts are starting to bear fruit.
Via
The Motley Fool
BioMedNewsBreaks — Annovis Bio Inc. (NYSE: ANVS) Release Promising Clinical Data As Global Alzheimer’s Disease Therapeutics Market Grows
August 07, 2024
Via
Investor Brand Network
Forget Tech! 3 Value Stocks That Could Win Big From Rate Cuts.
August 07, 2024
Several value stocks are poised to benefit richly from upcoming rate cuts that could happen as soon as September when the Fed reconvenes.
Via
InvestorPlace
Topics
Economy
Exposures
Interest Rates
3 Dividend Growth Stocks to Buy Hand Over Fist in August
August 07, 2024
There are blue-chip bargains paying large and growing dividends in the healthcare space.
Via
The Motley Fool
Lucrative Incentive for Biotechs as Global Alzheimer’s Disease Therapeutics Market Forecasted to Reach $30.8 Billion By 2033
August 06, 2024
EQNX::TICKER_START (NYSE:ANVS),(NYSE:PFE),(NYSE:LLY),(NYSE:GSK),(NYSE:NVO) EQNX::TICKER_END
Via
FinancialNewsMedia
Lucrative Incentive for Biotechs as Global Alzheimer's Disease Therapeutics Market Forecasted to Reach $30.8 Billion By 2033
August 06, 2024
From
FN Media Group LLC
Via
GlobeNewswire
3 Cheap Stocks to Buy in August for Under $50
August 06, 2024
It is never too early or too late to start investing, so choose these cheap stocks under $50 to start building your portfolio.
Via
InvestorPlace
3 Unstoppable Dividend Stocks Yielding More Than 4% for Income-Seeking Investors to Buy in August and Hold Forever
August 06, 2024
The dividend payments you can receive from these high-yield stocks are yours to keep, regardless of a market correction.
Via
The Motley Fool
Is It Too Late to Buy Vertex Pharmaceuticals Stock?
August 06, 2024
Shares of the rare disease drugmaker are already up more than 40% over the past year.
Via
The Motley Fool
Volatility Spikes: 3 Low Beta Stocks To Buy
August 06, 2024
Over recent months, several low-beta stocks have enjoyed positive earnings estimate revisions. For those looking for a higher level of defense, let’s take a closer look at each.
Via
Talk Markets
Small-Cap Cancer-Focused Nuvation Bio Pulls Plug On Early-Stage Program After Considering Phase 1 Solid Tumor Data
August 05, 2024
Nuvation Bio halts its NUV-868 BET inhibitor program after Phase 1 study analysis. The decision impacts solid tumor treatments in ovarian, pancreatic, and mCRPC cancers, focusing instead on late-stage...
Via
Benzinga
Moderna Lost 27% Of Its Value Over Two Days. It Just Crumbled Again.
August 05, 2024
Moderna sustained a rare downgrade on Monday following its guidance cut for the year.
Via
Investor's Business Daily
BioNTech's Q2 Loss Widens Amid Low Demand For Its Pfizer-Partnered COVID-19 Vaccine, Increases R&D Spending On New Cancer Products
August 05, 2024
BioNTech posted a significant Q2 2024 loss of 807.8 million euros. Sales dropped to 128.7 million euros as the demand for COVID-19 vaccines shifted. R&D expenses rose due to late-stage oncology...
Via
Benzinga
Exposures
COVID-19
Investing $100,000 in These 7 High-Yield Dividend Stocks Could Generate Over $7,000 in Annual Passive Income
August 04, 2024
Making passive income should be easy with these great stocks.
Via
The Motley Fool
2 Ultra-High-Yield Dividend Stocks to Buy in August and Hold at Least a Decade
August 03, 2024
With an average yield above 7% at recent prices, these stocks could give your passive income stream a big boost.
Via
The Motley Fool
Is This Decision by Pfizer Bad News for Eli Lilly?
August 03, 2024
Lilly's revenue gains have helped its stock to roar higher.
Via
The Motley Fool
Moderna Stock Trading Lower On Dismal Guidance, Analysts Cuts Price Targets Noting Competitive Pressure From GSK, Pfizer
August 02, 2024
Moderna cuts its 2024 sales forecast due to weaker demand for COVID-19 vaccines. Sales now expected between $3B-$3.5B, down from $4B. Analysts adjust price targets, citing competitive pressures from...
Via
Benzinga
Exposures
COVID-19
What Are the Hottest Biotech Stocks Right Now? 3 Top Picks.
August 02, 2024
Figuring out the hottest biotech stocks can be as simple as looking at the most traded stocks by volume in the last 24 hours.
Via
InvestorPlace
Stock Market Takes Bearish Turn; Apple, Microsoft, Meta, Amazon, AMD In Focus: Weekly Review
August 02, 2024
Apple and Meta had strong results, while AI spending remains robust.
Via
Investor's Business Daily
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
7 Subdued Blue-Chip Stocks That Will Reward Patient Investors
August 02, 2024
These are the blue-chip stocks to buy as they represent companies with strong fundamentals and growth acceleration possibility.
Via
InvestorPlace
Are Eli Lilly and Novo Nordisk Too Expensive For You? Here Are 4 Other Potential Weight Loss Stocks You May Want to Consider Right Now.
August 02, 2024
The popularity surrounding weight loss drugs such as Mounjaro and Ozempic has brought Eli Lilly and Novo Nordisk newfound growth.
Via
The Motley Fool
Bargain-Hunters Paradise: 7 Value Stocks That Are Too Cheap to Ignore
August 01, 2024
These cheap value stocks are priced right for any bargain hunters seeking deals in the market at the moment.
Via
InvestorPlace
Phio Pharmaceuticals Announces New Chief Financial Officer
August 01, 2024
Marlborough, Massachusetts--(Newsfile Corp. - August 1, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical stage biotechnology company whose proprietary...
Via
Newsfile
Topics
Initial Public Offering
Exposures
Securities Market
Moderna Slashes Its Outlook On 'Very Low' European Sales Despite Quarterly Beat
August 01, 2024
Moderna delivered nearly double the sales analysts expected in the second quarter.
Via
Investor's Business Daily
Pfizer Just Confirmed It's a Dividend Investor's Dream Stock
August 01, 2024
This big pharma stock gives investors juicy and reliable dividends plus the potential for future growth.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.